[{"NetIncomeLoss_2_Q2_USD":376000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-191000000.0,"PaymentsForRestructuring_2_Q2_USD":53000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":3000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":7000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-53000000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":745000000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":49000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":359000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":67.27,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.4859,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.9718,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":24000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":1000000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":40000000.0,"AssetsCurrent_0_Q2_USD":30113000000.0,"RestructuringCharges_2_Q2_USD":57000000.0,"RestructuringCharges_1_Q2_USD":20000000.0,"Assets_0_Q2_USD":44719000000.0,"CommonStockSharesIssued_0_Q2_shares":327000000.0,"UnrecognizedTaxBenefits_0_Q2_USD":989000000.0,"GainLossRelatedToLitigationSettlement_1_Q2_USD":-32000000.0,"GainLossRelatedToLitigationSettlement_2_Q2_USD":-1070000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q2_USD":13000000.0,"TreasuryStockValue_0_Q2_USD":2009000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":1000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":30000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4000000.0,"TreasuryStockShares_0_Q2_shares":33000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":39765000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":77115000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":1147000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":2284000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":46000000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":35000000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":499000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-504000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":14000000.0,"CommonStockValue_0_Q2_USD":2778000000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"IncomeTaxExpenseBenefit_1_Q2_USD":203000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":613000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":12000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":19000000.0,"Revenues_2_Q2_USD":80606000000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"RestructuringCosts_2_Q2_USD":41000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":295000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":295000000.0,"MinorityInterest_0_Q2_USD":4000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":398000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":3174000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":67.08,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-1000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":51000000.0,"Revenues_1_Q2_USD":41541000000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":404000000.0,"Dividends_1_Q2_USD":144000000.0,"Dividends_2_Q2_USD":289000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3737000000.0,"OtherAssetsNoncurrent_0_Q2_USD":1118000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":113000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":228000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1861000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":150000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":663000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1256000000.0,"OtherAssetsCurrent_0_Q2_USD":3205000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-344000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.476,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":2.597,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":5877000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":427000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":664000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":34000000.0,"StockholdersEquityOther_1_Q2_USD":0.0,"SeveranceCosts1_1_Q2_USD":8000000.0,"SeveranceCosts1_2_Q2_USD":32000000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_2_Q2_shares":2000000.0,"InterestExpense_1_Q2_USD":46000000.0,"InterestExpense_2_Q2_USD":91000000.0,"AccountsPayableCurrent_0_Q2_USD":23235000000.0,"LiabilitiesCurrent_0_Q2_USD":25750000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":294000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":293000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1487000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":21000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":33000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":6720000000.0,"Goodwill_0_Q2_USD":8399000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":34000000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2502000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2703000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":1.27,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":2.13,"NetIncomeLoss_1_Q2_USD":629000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2386000000.0,"ReceivablesNetCurrent_0_Q2_USD":8728000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q2_USD":0.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_Q2_USD":-9000000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":51000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2679000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1975000000.0,"AccountsPayableCurrentAndNoncurrent_0_Q2_USD":23200000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":1000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":2000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":289000000.0,"GrossProfit_1_Q2_USD":1776000000.0,"GrossProfit_2_Q2_USD":3491000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":329000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":278000000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":10274000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"PreferredStockValue_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":5853000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"RestructuringReserve_0_Q2_USD":84000000.0,"InventoryNet_0_Q2_USD":14443000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":44719000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":427000000.0,"OperatingIncomeLoss_1_Q2_USD":461000000.0,"OperatingIncomeLoss_2_Q2_USD":-163000000.0,"CommonStockSharesAuthorized_0_Q2_shares":755000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":3000000.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1_Q2_USD":0.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_2_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":51000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-236000000.0,"StockholdersEquityOther_2_Q2_USD":-2000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":500000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":23000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":966000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1255000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q2_USD":13000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2_Q2_USD":18000000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":2.14,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":1.28,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":51000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5000000.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":174000000.0,"StockholdersEquity_0_Q2_USD":1971000000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":2000000.0,"ProfitLoss_1_Q2_USD":630000000.0,"ProfitLoss_2_Q2_USD":377000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":217000000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":11102000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":428000000.0,"Ticker":"CAH","CIK":"721371","name":"CARDINAL HEALTH INC","OfficialName":"Cardinal Health Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"17377290506.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20210205"}]